Document Type : Systematic Review
Author
Clinical Research Development Unit (FACRDU), Department of geriatrician, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
10.22034/mphrj.2026.612971.1141
Abstract
Sleep-disordered breathing (SDB), particularly obstructive sleep apnea (OSA), is increasingly recognized as a multisystem disorder associated with endocrine disturbances and adverse cognitive outcomes. Recurrent intermittent hypoxia, sleep fragmentation, and autonomic activation may contribute to hypothalamic–pituitary–adrenal axis dysfunction, insulin resistance, altered adipokine secretion, systemic inflammation, and oxidative stress. These mechanisms may interact to impair cerebral vascular regulation, neuronal integrity, and cognitive performance. This systematic evidence review aimed to examine the associations between SDB, endocrine dysregulation, and cognitive impairment, with particular emphasis on potentially modifiable biological pathways and clinical outcomes. Relevant evidence was organized across four domains: respiratory and hypoxic mechanisms, endocrine and metabolic alterations, neuroinflammation and cognitive dysfunction, and treatment-related outcomes. Findings from previous systematic reviews, meta-analyses, observational studies, and randomized controlled trials were synthesized. Evidence indicates that SDB is associated with an increased risk of subsequent cognitive impairment, although associations vary across cognitive domains. A population-based meta-analysis involving 4,288,419 individuals reported a 26% increased risk of cognitive impairment among individuals with SDB (RR = 1.26, 95% CI [1.05, 1.50]). Executive functioning demonstrated a small adverse association, whereas global cognition and memory findings were less consistent. Endocrine evidence suggests abnormalities in leptin, ghrelin, glucose regulation, and potentially HPA-axis activity; however, cortisol findings remain heterogeneous. Continuous positive airway pressure (CPAP) therapy may improve selected cognitive functions, particularly cognitive flexibility, although benefits are not consistently observed across all domains. Overall, SDB represents a potentially modifiable contributor to endocrine and cognitive dysfunction. Further longitudinal and intervention studies are required to establish causal pathways, identify responsive patient subgroups, and determine whether integrated respiratory and metabolic treatment can prevent long-term cognitive deterioration.
Keywords
Subjects